Sanofi to Acquire Blueprint Medicines Corporation Following Successful Tender Offer Completion

Sanofi is set to acquire Blueprint Medicines Corporation following the successful completion of a tender offer by its subsidiary, Rothko Merger Sub, Inc. The merger will result in Blueprint Medicines becoming a wholly-owned subsidiary of Sanofi, with the latter remaining the surviving corporation post-merger. This announcement highlights a significant corporate event in the pharmaceutical industry.